Azura Ophthalmics' Series B Round

Azura Ophthalmics raised a round of funding on October 10, 2017.

Azura Ophthalmics is a clinical-stage biotechnology company developing a portfolio of compounds in combination with a novel drug delivery platform to advance a portfolio of treatments for Meibomian gl…

Articles about Azura Ophthalmics' Series B Round: